BioN­Tech-backed ADC mak­er Du­al­i­ty­Bio plans IPO on Hong Kong ex­change

An­ti­body-drug con­ju­gates start­up Du­al­i­ty Bi­o­log­ics will join the pub­lic mar­kets on Tues­day via an ini­tial pub­lic of­fer­ing on the Hong Kong Stock Ex­change.

The Shang­hai …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER